AFib Backgrounder
The IRIS Advantage
Current Treatment
Corporate Background
Abstracts and Publications
Other Applications
The Direct Endocardial Visualization Ablation Catheter – IRIS™ System for the treatment of paroxysmal Atrial Fibrillation (AF) is the first product in the IRIS Catheter family.
Voyage Medical is committed to developing novel direct endocardial visualization and therapeutic interventions that enable physicians to better address cardiac conditions and improve patient quality of life.
The Company is also exploring applications for its direct visualization and treatment technologies outside of AF. The potential focus is on unmet clinical needs in areas such as structural heart disease, the delivery of biologics and other complex cardiac arrhythmia indications.
© 2012 Voyage Medical, Inc All Rights Reserved